BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32918120)

  • 41. Proliferative verrucous leukoplakia: a case report.
    Lopes MA; Pazoki AE; Ord RA
    Gen Dent; 2000; 48(6):708-10. PubMed ID: 12004667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proliferative verrucous leukoplakia: a concise update.
    Bagan J; Scully C; Jimenez Y; Martorell M
    Oral Dis; 2010 May; 16(4):328-32. PubMed ID: 20233330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biomarkers of malignant transformation in oral leukoplakia: from bench to bedside.
    Cai X; Zhang J; Zhang H; Li T
    J Zhejiang Univ Sci B; 2023 May; 24(10):868-882. PubMed ID: 37752089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid progression of an idiopathic leukoplakia to a proliferative verrucous leukoplakia lesion and then squamous cell carcinoma.
    Dal Vechio A; Nakagima E; Azevedo LH; Alves FA; Migliari DA
    Quintessence Int; 2012; 43(7):583-5. PubMed ID: 22670253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proliferative verrucous leukoplakia: a potentially malignant disorder involving periodontal sites.
    Gandolfo S; Castellani R; Pentenero M
    J Periodontol; 2009 Feb; 80(2):274-81. PubMed ID: 19186968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Study of testicular cancer gene expression in samples of oral leukoplakia and squamous cell carcinoma of the mouth].
    Skorodumova LO; Muraev AA; Zakharova ES; Shepelev MV; Korobko IV; Zaderenko IA; Ivanov SIu; Gnuchev NV; Georgiev GP; Larin SS
    Vopr Onkol; 2012; 58(4):486-92. PubMed ID: 23607202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of malignant transformation in oral leukoplakia and proliferative verrucous leukoplakia: An observational prospective study including the DNA ploidy status.
    Pentenero M; Castagnola P; Castillo FV; Isaevska E; Sutera S; Gandolfo S
    Head Neck; 2023 Oct; 45(10):2589-2604. PubMed ID: 37563936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proliferative verrucous leukoplakia: an aggressive form of oral leukoplakia.
    Shopper TP; Brannon RB; Stalker WH
    J Dent Hyg; 2004; 78(3):7. PubMed ID: 16197744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.
    Miyahara LAN; Pontes FSC; Burbano RMR; Conte Neto N; Guimarães DM; Fonseca FP; Pontes HAR
    Histopathology; 2018 Jan; 72(2):330-338. PubMed ID: 28858374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transformation of proliferative verrucous leukoplakia to oral carcinoma: a ten years follow-up.
    Navarro CM; Sposto MR; Sgavioli-Massucato EM; Onofre MA
    Med Oral; 2004; 9(3):229-33. PubMed ID: 15122125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer-associated fibroblasts are an infrequent finding in the microenvironment of proliferative verrucous leukoplakia-associated squamous cell carcinoma.
    Akrish SJ; Rachmiel A; Sabo E; Vered M; Ben-Izhak O
    J Oral Pathol Med; 2017 May; 46(5):353-358. PubMed ID: 27681951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exome sequencing of oral leukoplakia and oral squamous cell carcinoma implicates DNA damage repair gene defects in malignant transformation.
    Farah CS; Jessri M; Bennett NC; Dalley AJ; Shearston KD; Fox SA
    Oral Oncol; 2019 Sep; 96():42-50. PubMed ID: 31422212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proliferative verrucous leukoplakia, squamous cell carcinoma and axillary metastasis.
    Gouvêa AF; Moreira AE; Reis RR; de Almeida OP; Lopes MA
    Med Oral Patol Oral Cir Bucal; 2010 Sep; 15(5):e704-8. PubMed ID: 20173705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proliferative verrucous leukoplakia: high incidence of gingival squamous cell carcinoma.
    Bagan JV; Jimenez Y; Sanchis JM; Poveda R; Milian MA; Murillo J; Scully C
    J Oral Pathol Med; 2003 Aug; 32(7):379-82. PubMed ID: 12846783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene expression profiles of oral leukoplakia and carcinoma: genome-wide comparison analysis using oligonucleotide microarray technology.
    Odani T; Ito D; Li MH; Kawamata A; Isobe T; Iwase M; Nagumo M
    Int J Oncol; 2006 Mar; 28(3):619-24. PubMed ID: 16465365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of survivin in oral leukoplakia and oral lichen planus.
    Lalitha C; Hussain MK; Kodangal S; Swapna LA; Dantu R; Nagabhyrava P
    Minerva Dent Oral Sci; 2022 Jun; 71(3):125-130. PubMed ID: 34672483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proliferative verrucous leukoplakia: report of a case with characteristic long-term progression.
    Vigliante CE; Quinn PD; Alawi F
    J Oral Maxillofac Surg; 2003 May; 61(5):626-31. PubMed ID: 12730844
    [No Abstract]   [Full Text] [Related]  

  • 59. Oral cancer on the gingiva in patients with proliferative leukoplakia: A study of 30 cases.
    Bagan J; Murillo-Cortes J; Leopoldo-Rodado M; Sanchis-Bielsa JM; Bagan L
    J Periodontol; 2019 Oct; 90(10):1142-1148. PubMed ID: 31074011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
    Kikegawa A
    Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.